A new generation of drugs, MabThera, Tocilizumab and Orencia could revolutionise the treatment of people suffering with rheumatoid arthritis. Reseach in Austria showed the drugs reduced symptoms and slowed progression of the disease.
The drugs work by targeting the immune system but do have side effects, and although two of the drugs are licensed for use NHS advisers have yet to give doctors the green light to prescribe.
The three drugs do show a lot of promise as each drug diminishes signs and symptoms of rheumatoid arthritis and improve physical function and health status and retard progression of joint damage.
The National Institute for Health and Clinical Excellance, which issues guidelines on which medicines should be available on the NHS is currently looking at the use of MabThera and Orencia for treating rheumatoid arthritis.
Source : BBC Online
Date : 13/06/2007
Click HERE to read full Article
Further Reading :
http://www.mabthera-ra.com
http://www.orencia.com
All articles are taken from external sources and are not the views or expressions of Comfort Plus Products